# Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus

> **NCT01038505** · PHASE4 · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Living Donor Kidney Transplants Patients

## Interventions

- **DRUG:** Tacrolimus, Myfortic and Sirolimus

## Key facts

- **NCT ID:** NCT01038505
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lost funding source
- **Last updated:** 2024-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038505, "Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01038505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*